News
Meda announced new results from its Phase 3 study of Dymista (azelastine HCl and fluticasone propionate; Meda) nasal spray for the treatment of allergic rhinitis. Data from three randomized, ...
Meda announced positive results from its Phase 3 trial of Dymista (azelastine HCl and fluticasone propionate) nasal spray in patients with seasonal allergic rhinitis. The randomized, double-blind, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results